NCT03559387 2019-02-12
Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia
Prolong Pharmaceuticals
Phase 2 Terminated
Clinical Trials
1 trialsPhase 2 × Chemotherapy-induced Neutropenia × pegylated granulocyte colony-stimulating factor × Clear all